Rishab Jain
Rishab Jain | |
|---|---|
 | |
| Nationality | American |
| Alma mater | Harvard University |
| Occupation |
|
| Known for | Scientific innovations in AI and biotechnology |
| Title | Founder and CEO, Claisen |
| Awards |
|
| Website | rishabjaink |
Rishab Jain is an American scientist, innovator, and entrepreneur. He is the founder and CEO of Claisen, a biotechnology startup developing AI-powered treatments for gut health. Jain gained early recognition for his pioneering work in artificial intelligence applied to cancer treatment, and he has been widely recognized as one of the leading young scientists of his generation.
Early life and education
At the age of 13, Jain was named America's Top Young Scientist for developing an AI tool that helps pinpoint the pancreas more accurately during radiotherapy for pancreatic cancer. The invention significantly improved treatment effectiveness and minimized damage to surrounding healthy tissue.
He has since received multiple awards for his scientific contributions, including being named one of TIME Magazine’s 25 Most Influential Teens in 2018. He is also a recipient of the Regeneron Young Scientist Award and the Gloria Barron Prize for Young Heroes.
Jain is currently an undergraduate student at Harvard University, where he is studying neuroscience. His academic work combines AI and human neuronal data to better understand cognition.
Career
In addition to his scientific research, Jain is the founder and CEO of Claisen, a biotechnology startup focused on developing AI-powered treatments for gut health. Claisen is described as a "gut health startup founded in 2025 by Harvard entrepreneur Rishab Jain" offering personalized treatment for conditions like GERD, heartburn, IBS, bloating, gas, and constipation. The company is framed as "building the world’s first GI clinic powered entirely by AI".
Awards and recognition
- America's Top Young Scientist (2017)
- TIME 25 Most Influential Teens (2018)
- Regeneron Young Scientist Award
- Gloria Barron Prize for Young Heroes